Jiangsu Hengrui Medicine Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 0.16%

Jiangsu Hengrui Medicine Co Ltd (600276) has an Asset Resilience Ratio of 0.16% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read total liabilities of Jiangsu Hengrui Medicine Co Ltd for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥111.45 Million

≈ $16.31 Million USD Cash + Short-term Investments

Total Assets

CN¥68.33 Billion

≈ $10.00 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2000–2024)

This chart shows how Jiangsu Hengrui Medicine Co Ltd's Asset Resilience Ratio has changed over time. See 600276 total equity for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Jiangsu Hengrui Medicine Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Jiangsu Hengrui Medicine Co Ltd (600276) market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥111.45 Million	0.16%
Total Liquid Assets	CN¥111.45 Million	0.16%

Asset Resilience Insights

Limited Liquidity: Jiangsu Hengrui Medicine Co Ltd maintains only 0.16% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Jiangsu Hengrui Medicine Co Ltd Industry Peers by Asset Resilience Ratio

Compare Jiangsu Hengrui Medicine Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Regencell Bioscience Holdings Ltd NASDAQ:RGC	Drug Manufacturers - Specialty & Generic	43.05%
Changchun High & New Technology Industries Group Inc SHE:000661	Drug Manufacturers - Specialty & Generic	3.73%
Yuhan Corp. KO:000100	Drug Manufacturers - Specialty & Generic	0.99%
Tonghua Dongbao Pharmaceutical Co Ltd SHG:600867	Drug Manufacturers - Specialty & Generic	1.96%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%
Guangdong Zhongsheng Pharmaceutical Co Ltd SHE:002317	Drug Manufacturers - Specialty & Generic	6.62%
Guobang Pharma Ltd SHG:605507	Drug Manufacturers - Specialty & Generic	8.47%

Annual Asset Resilience Ratio for Jiangsu Hengrui Medicine Co Ltd (2000–2024)

The table below shows the annual Asset Resilience Ratio data for Jiangsu Hengrui Medicine Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	0.55%	CN¥273.34 Million ≈ $40.00 Million	CN¥50.14 Billion ≈ $7.34 Billion	+0.32pp
2023-12-31	0.23%	CN¥99.05 Million ≈ $14.49 Million	CN¥43.78 Billion ≈ $6.41 Billion	-6.29pp
2022-12-31	6.52%	CN¥2.76 Billion ≈ $403.95 Million	CN¥42.36 Billion ≈ $6.20 Billion	-6.45pp
2021-12-31	12.96%	CN¥5.09 Billion ≈ $744.88 Million	CN¥39.27 Billion ≈ $5.75 Billion	-3.24pp
2020-12-31	16.21%	CN¥5.63 Billion ≈ $823.55 Million	CN¥34.73 Billion ≈ $5.08 Billion	-14.71pp
2019-12-31	30.92%	CN¥8.52 Billion ≈ $1.25 Billion	CN¥27.56 Billion ≈ $4.03 Billion	-0.67pp
2018-12-31	31.59%	CN¥7.06 Billion ≈ $1.03 Billion	CN¥22.36 Billion ≈ $3.27 Billion	+6.36pp
2017-12-31	25.22%	CN¥4.55 Billion ≈ $665.84 Million	CN¥18.04 Billion ≈ $2.64 Billion	+14.55pp
2016-12-31	10.68%	CN¥1.53 Billion ≈ $223.91 Million	CN¥14.33 Billion ≈ $2.10 Billion	+7.13pp
2008-12-31	3.55%	CN¥80.04 Million ≈ $11.71 Million	CN¥2.25 Billion ≈ $329.88 Million	-9.90pp
2007-12-31	13.45%	CN¥270.88 Million ≈ $39.64 Million	CN¥2.01 Billion ≈ $294.67 Million	+12.70pp
2006-12-31	0.75%	CN¥10.97 Million ≈ $1.60 Million	CN¥1.46 Billion ≈ $213.35 Million	-4.25pp
2003-12-31	5.00%	CN¥72.59 Million ≈ $10.62 Million	CN¥1.45 Billion ≈ $212.28 Million	-1.01pp
2002-12-31	6.02%	CN¥72.49 Million ≈ $10.61 Million	CN¥1.20 Billion ≈ $176.27 Million	-4.93pp
2001-12-31	10.95%	CN¥122.49 Million ≈ $17.92 Million	CN¥1.12 Billion ≈ $163.75 Million	-1.60pp
2000-12-31	12.55%	CN¥123.75 Million ≈ $18.11 Million	CN¥986.27 Million ≈ $144.32 Million	--

pp = percentage points

About Jiangsu Hengrui Medicine Co Ltd

SHG:600276 China Drug Manufacturers - Specialty & Generic

Market Cap

$50.29 Billion

CN¥343.70 Billion CNY

Market Cap Rank

#526 Global

#27 in China

Share Price

CN¥53.88

Change (1 day)

-2.02%

52-Week Range

CN¥50.69 - CN¥72.47

All Time High

CN¥193.72